Immediate Impact
88 standout
Citing Papers
Steatotic liver disease
2024 Standout
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review
2023 Standout
Works of R. Deydier being referenced
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies
2006
Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R. Deydier | 337 | 322 | 3 | 16 | 4 | 355 | |
| MY Maïga | 255 | 236 | 26 | 19 | 6 | 302 | |
| Rousselet Mc | 255 | 241 | 8 | 21 | 7 | 300 | |
| Nancy Fryzek | 231 | 246 | 10 | 12 | 7 | 307 | |
| F. Imbert Bismut | 312 | 277 | 6 | 30 | 5 | 346 | |
| Alice Grignaschi | 313 | 301 | 9 | 38 | 9 | 403 | |
| Norio Hayashi | 270 | 285 | 29 | 12 | 8 | 362 | |
| Shigemune Bekki | 303 | 301 | 13 | 26 | 9 | 365 | |
| S. Cerioni | 259 | 251 | 40 | 12 | 5 | 382 | |
| Michael R. Charlton | 261 | 261 | 5 | 32 | 7 | 362 | |
| C Gueli | 229 | 236 | 5 | 64 | 7 | 310 |
All Works
Loading papers...